TP53 and neoplasm: Induced reprogramming of malignant (chronic myeloid leukemia) cells with abnormal or deleted p53 raised the efficiency of the generation of iPSCs and the frequency of tumor formation after the transplantation of these reprogrammed malignant cells into animals.